CD4 and neoplasm: Multiple immune cell markers were evaluated, including T cell markers, CD3, CD4, CD8; the macrophage marker CD68; CK-SOX10 tumor marker; and immune modulatory factors, PD1, PDL1, FOXP3, IFN-γ, NOS2, and COX2.